Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Virology Journal|May 25, 2006
Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphologyReed F Johnson, Peter Bell, Ronald N HartyAnnual Review of Medicine|October 1, 2016
Toward an Effective Ebola Virus VaccineRohan Keshwara, Reed F Johnson, Matthias J SchnellJournal of Virology|June 29, 2004
Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particlesJillian M Licata, Reed F Johnson, Ziying Han, et al.Clinical and Vaccine Immunology : CVI|June 20, 2014
Matched longitudinal analysis of biomarkers associated with survivalLori E Dodd, Reed F Johnson, Joseph E Blaney, et al.Journal of Virology|May 16, 2006
Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particlesReed F Johnson, Sarah E McCarthy, Peter J Godlewski, et al.Journal of Virology|August 19, 2007
Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and buddingSarah E McCarthy, Reed F Johnson, Yong-An Zhang, et al.NPJ Vaccines|April 25, 2019
Rabies-based vaccine induces potent immune responses against Nipah virusRohan Keshwara, Thomas Shiels, Elena Postnikova, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissueGuoli Shi, Tiansheng Li, Kin Kui Lai, et al.NPJ Vaccines|May 18, 2019
Erratum: Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virusRohan Keshwara, Thomas Shiels, Elena Postnikova, et al.Nature Communications|January 30, 2024
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissueGuoli Shi, Tiansheng Li, Kin Kui Lai, et al.Pageof 10